Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-RandomizeD FEasibility Trial of the Spur SystEm for the Treatment of Lesions in the InfraPoplitEal ArteRy

NCT03669458 is registered in ClinicalTrials.gov with ReFlow Medical, Inc. as lead sponsor.

NCT NCT03669458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03669458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-RandomizeD FEasibility Trial of the Spur SystEm for the Treatment of Lesions in the InfraPoplitEal ArteRy
Lead sponsor
ReFlow Medical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 6, 2017
Completion date
June 4, 2019
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia